RESUMO
The aim of this study was to compare intratumoural heterogeneity and longitudinal changes assessed by dynamic contrast-enhanced ultrasound (DCE-US) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in prostate tumour xenografts. In vivo DCE-US and DCE-MRI were obtained 24 h pre- (day 0) and post- (day 2) radiation treatment with a single dose of 7.5 Gy. Characterization of the tumour vasculature was determined by Brix pharmacokinetic analysis of the time-intensity curves. Histogram analysis of voxels showed significant changes (p < 0.001) from day 0 to day 2 in both modalities for kep , the exchange rate constant from the extracellular extravascular space to the plasma, and kel , the elimination rate constant of the contrast. In addition, kep and kel values from DCE-US were significantly higher than those derived from DCE-MRI at day 0 (p < 0.0001) for both groups. At day 2, kel followed the same tendency for both groups, whereas kep showed this tendency only for the treated group in intermediate-enhancement regions. Regarding kep median values, longitudinal changes were not found for any modality. However, at day 2, kep linked to DCE-US was correlated to MVD in high-enhancement areas for the treated group (p = 0.05). In contrast, correlation to necrosis was detected for the control group in intermediate-enhancement areas (p < 0.1). Intratumoural heterogeneity and longitudinal changes in tumour vasculature were assessed for both modalities. Microvascular parameters derived from DCE-US seem to provide reliable biomarkers during radiotherapy as validated by histology. Furthermore, DCE-US could be a stand-alone or a complementary technique.
Assuntos
Aumento da Imagem/métodos , Imageamento por Ressonância Magnética/métodos , Microvasos/diagnóstico por imagem , Imagem Multimodal/métodos , Neoplasias da Próstata/irrigação sanguínea , Neoplasias da Próstata/diagnóstico por imagem , Animais , Biomarcadores Tumorais/análise , Linhagem Celular Tumoral , Meios de Contraste/farmacologia , Gadolínio/farmacologia , Humanos , Masculino , Camundongos , Transplante de Neoplasias , Neoplasias da Próstata/radioterapia , Transplante Heterólogo , Carga Tumoral , UltrassonografiaRESUMO
The use of threshold or pacemaker system analyzers with widely different characteristics has introduced potential sources of error in the determination of the output voltage of pulse generators. This is further compounded by the availability of pulse generators with diverse waveform configurations and programmability capabilities. Because of this non-uniformity, the physician must have some rudimentary knowledge of waveform characteristics and appreciate the limitations of threshold or pacemaker system analyzers to avoid the unnecessary replacement of normally-functioning pulse generators.